Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
Frankfurt - Delayed Quote EUR

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5.F)

Compare
2.1400
+0.0200
+(0.94%)
At close: February 26 at 8:15:22 AM GMT+1
Currency in CNY All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
74,992,820.4736
74,992,820.4736
75,515,403.9948
70,788,155.0685
69,014,052.3470
Cost of Revenue
62,472,768.6817
62,472,768.6817
61,328,109.6149
57,510,951.7456
55,780,767.2814
Gross Profit
12,520,051.7919
12,520,051.7919
14,187,294.3799
13,277,203.3229
13,233,285.0656
Operating Expense
8,744,645.4094
8,744,645.4094
9,314,799.4470
8,730,402.6518
8,849,743.3668
Operating Income
3,775,406.3825
3,775,406.3825
4,872,494.9329
4,546,800.6711
4,383,541.6988
Net Non Operating Interest Income Expense
-35,078.8103
-35,078.8103
16,241.7554
173,573.2068
124,335.9853
Pretax Income
3,607,579.8718
3,607,579.8718
5,110,498.0296
5,043,244.0712
4,723,070.9435
Tax Provision
606,848.5285
606,848.5285
851,170.0693
789,873.7373
754,085.2245
Net Income Common Stockholders
2,835,496.1635
2,835,496.1635
4,055,678.6915
3,966,522.2185
3,719,877.6805
Basic EPS
2.11
1.74
2.50
2.44
2.29
Diluted EPS
2.11
1.74
2.50
2.44
2.29
Basic Average Shares
1,625,578.0120
1,625,857.8920
1,625,522.5220
1,625,623.8600
1,625,820.6650
Diluted Average Shares
1,625,578.0120
1,625,857.8920
1,625,522.5220
1,625,623.8600
1,625,820.6650
Total Operating Income as Reported
3,596,393.9126
3,596,393.9126
5,120,896.6813
5,074,399.6093
4,786,041.9998
Rent Expense Supplemental
35,549.5678
35,549.5678
31,312.5990
43,374.0487
45,431.1970
Total Expenses
71,217,414.0911
71,217,414.0911
70,642,909.0619
66,241,354.3974
64,630,510.6482
Net Income from Continuing & Discontinued Operation
2,835,496.1635
2,835,496.1635
4,055,678.6915
3,966,522.2185
3,719,877.6805
Normalized Income
3,220,295.0339
3,220,295.0339
4,097,994.7181
4,017,857.6765
3,656,093.6687
Interest Income
404,308.0705
404,308.0705
486,336.3489
626,789.1864
563,866.7052
Interest Expense
418,151.3178
418,151.3178
446,191.7329
434,408.0236
417,830.6232
Net Interest Income
-35,078.8103
-35,078.8103
16,241.7554
173,573.2068
124,335.9853
EBIT
4,025,731.1896
4,025,731.1896
5,556,689.7625
5,477,652.0949
5,140,901.5666
EBITDA
4,900,973.8642
4,900,973.8642
6,486,127.2425
6,221,480.3462
5,817,893.1383
Reconciled Cost of Revenue
62,472,768.6817
62,472,768.6817
61,328,109.6149
57,510,951.7456
55,780,767.2814
Reconciled Depreciation
875,242.6746
875,242.6746
929,437.4800
743,828.2514
676,991.5717
Net Income from Continuing Operation Net Minority Interest
2,835,496.1635
2,835,496.1635
4,055,678.6915
3,966,522.2185
3,719,877.6805
Total Unusual Items Excluding Goodwill
-462,618.1089
-462,618.1089
-50,772.3220
-60,868.7285
75,902.6194
Total Unusual Items
-462,618.1089
-462,618.1089
-50,772.3220
-60,868.7285
75,902.6194
Normalized EBITDA
5,363,591.9731
5,363,591.9731
6,536,899.5644
6,282,349.0747
5,741,990.5189
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
0.0002
Tax Effect of Unusual Items
-77,819.2386
-77,819.2386
-8,456.2954
-9,533.2705
12,118.6077
12/31/2021 - 7/5/2012

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

AEQ.MU Aequus Pharmaceuticals Inc
0.0410
0.00%
 
AWY0.SG Percheron Therapeutics Ltd
0.0055
+10.00%
 
TRXPF Torii Pharmaceutical Co., Ltd.
24.57
0.00%
 
PB8.MU Phibro Animal Health Corp
17.95
-4.01%
 
MRK.HM Merck KGaA
119.40
-2.93%
 
ZOE.MU Zoetis Inc
144.38
-2.66%
 
LDE.DU Lifecore Biomedical Inc
4.6800
-22.64%
 
FFEA.MU Faes Farma SA
4.0100
+1.52%
 
CVJ.F Cann Group Limited
0.0070
0.00%
 
PSG.DU PharmaSGP Holding SE
23.80
+0.85%